Chemotherapy (control)

DRUG2 trials

Sponsors

Medifocus, Inc., Fudan University

Conditions

Breast CancerColorectal CancerFAPI PETPeritoneal (Metastatic) Cancer

Phase 2

Comparing 18F-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus Second-Line Standard Therapy in Colorectal Cancer With Peritoneal Metastasis

Active, not recruitingNCT07079462

Fudan UniversityColorectal Cancer, FAPI PET, Peritoneal (Metastatic) Cancer

Start: 2024-08-07End: 2028-01-31Updated: 2026-08-12

Phase 3

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors

Medifocus, Inc.Breast Cancer

Start: 2010-11-30End: 2016-12-31Target: 238Updated: 2015-09-24

Related Papers

A prospective randomized controlled trial of FAPI PET/CT-guided radiotherapy combined with second-line standard systemic treatment and cadonilimab versus second-line standard systemic treatment alone in patients with peritoneal metastasis from colorectal cancer (TORCH-PM01).

Journal of Clinical Oncology2026-05-27